Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Anya Pavlovsky"'
Autor:
Anjana Shenoy, Nishanth Belugali Nataraj, Gili Perry, Fabricio Loayza Puch, Remco Nagel, Irina Marin, Nora Balint, Noa Bossel, Anya Pavlovsky, Iris Barshack, Bella Kaufman, Reuven Agami, Yosef Yarden, Maya Dadiani, Tamar Geiger
Publikováno v:
Molecular Systems Biology, Vol 16, Iss 9, Pp n/a-n/a (2020)
Abstract Tumor relapse as a consequence of chemotherapy resistance is a major clinical challenge in advanced stage breast tumors. To identify processes associated with poor clinical outcome, we took a mass spectrometry‐based proteomic approach and
Externí odkaz:
https://doaj.org/article/5c738af05ac8485a9c300273476af2be
Autor:
Noa Bossel Ben-Moshe, Shlomit Gilad, Gili Perry, Sima Benjamin, Nora Balint-Lahat, Anya Pavlovsky, Sharon Halperin, Barak Markus, Ady Yosepovich, Iris Barshack, Einav Nili Gal-Yam, Eytan Domany, Bella Kaufman, Maya Dadiani
Publikováno v:
BMC Genomics, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background The main bottleneck for genomic studies of tumors is the limited availability of fresh frozen (FF) samples collected from patients, coupled with comprehensive long-term clinical follow-up. This shortage could be alleviated by usin
Externí odkaz:
https://doaj.org/article/cfcc7ddcd28e40689c873610ed73be65
Autor:
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint-Lahat, Shlomit Gilad, Dana Morzaev-Sulzbach, Anjana Shenoy, Noa Bossel Ben-Moshe, Anya Pavlovsky, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal-Yam
Emerging evidence reinforce the role of non-genetic adaptive resistance to chemotherapy, that involves rewiring of transcriptional programs in surviving tumors. We combined longitudinal transcriptomics with temporal pattern analysis to dissect patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c18865b32c45878d677e042ac87d157a
https://doi.org/10.1101/2023.02.09.527790
https://doi.org/10.1101/2023.02.09.527790
Autor:
Anya Pavlovsky, Maya Dadiani, Nora Balint, Fabricio Loayza Puch, Noa Bossel, Irina Marin, Gili Perry, Anjana Shenoy, Yosef Yarden, Reuven Agami, Iris Barshack, Remco Nagel, Nishanth Belugali Nataraj, Bella Kaufman, Tamar Geiger
Publikováno v:
Molecular Systems Biology
Molecular Systems Biology, Vol 16, Iss 9, Pp n/a-n/a (2020)
Molecular Systems Biology, Vol 16, Iss 9, Pp n/a-n/a (2020)
Tumor relapse as a consequence of chemotherapy resistance is a major clinical challenge in advanced stage breast tumors. To identify processes associated with poor clinical outcome, we took a mass spectrometry‐based proteomic approach and analyzed
Autor:
Bella Kaufman, Anya Pavlovsky, Shlomit Gilad, Maya Dadiani, Iris Barshack, Gili Perry, Ady Yosepovich, Nora Balint-Lahat, Sharon Halperin, Noa Bossel Ben-Moshe, Barak Markus, Einav Nili Gal-Yam, Sima Benjamin, Eytan Domany
Publikováno v:
BMC Genomics, Vol 19, Iss 1, Pp 1-11 (2018)
BMC Genomics
BMC Genomics
Background The main bottleneck for genomic studies of tumors is the limited availability of fresh frozen (FF) samples collected from patients, coupled with comprehensive long-term clinical follow-up. This shortage could be alleviated by using existin
Autor:
Iris Barshack, Bella Kaufman, Nora Balint-Lahat, Maya Dadiani, Gili Perry, Anya Pavlovsky, Anjana Shenoy, Einav Nili Gal-Yam, Tamar Geiger, Gilgi Friedlander
Publikováno v:
Cancer Research. 80:P6-03
Background: Understanding resistance mechanisms to chemotherapy is key to improving therapeutic outcomes. Despite the considerable importance of tumor drug resistance to cancer morbidity and mortality, our comprehension of the various molecular mecha
Autor:
E. Nili Gal Yam, S. Kahana, Adi Zundelevich, Maya Dadiani, Bella Kaufman, Iris Barshack, Tal Sela, Moran Gadot, Amit Itay, Anya Pavlovsky
Publikováno v:
Annals of Oncology. 30:iii8
Autor:
Jacob Shoham, Yedida Sharabi, Noah Samuels, Cheppail Ramachandran, Yair Maimon, Steven J. Melnick, Anya Pavlovsky, Itzchak H Rachmut
Publikováno v:
OncoTargets and therapy
Itzchak H Rachmut,1 Noah Samuels,2,* Steven J Melnick,3 Cheppail Ramachandran,4 Yedida Sharabi,1 Anya Pavlovsky,1 Yair Maimon,5 Jacob Shoham1 1The Gonda-Goldschmied Center, Bar-Ilan University, Ramat-Gan, Israel; 2Center for Integrative Complementary
Autor:
Anya Pavlovsky, Einav Nili Gal-Yam, Adi Zundelevich, Tal Sela, Iris Barshack, Moran Gadot, Maya Dadiani, Daniela Necula, Irina Marin, Bella Kaufman, Smadar Kahana-Edwin
Publikováno v:
Cancer Research. 78:657-657
Emerging mutations in the ESR1 gene that encodes for estrogen receptor (ER) have been recently associated with resistance to endocrine therapy in ER positive metastatic breast cancer patients. These mutations promote the active conformation of the re